The one-and-only rapid point-of-care test that can detect MMP-9

InflammaDry detects elevated levels of MMP-9, a Key Inflammatory biomarker for ocular surface disease.

Complete results in as fast as 10 minutes.

Disposable test, requires just 4 easy steps.

No additional equipment needed to interpret.

Watch Dr. Beck explain the advantages of testing inflammation in the Dry Eye Diagnosis process:

An optimal treatment pathway for Dry Eye disease.

InflammaDry is the only rapid, in-office CLIA-waived test that detects elevated levels of MMP-9 an inflammatory marker that is consistently elevated in the tears of patients with dry eye disease. InflammaDry accurately identifies patients with oracular surface disease allowing for an optimal treatment pathway.

  • CLIA Waved
  • Results in minutes
  • 4 Simple steps
  • Minimally Invasive
  • Requires no special equipment

Clinical benefits


Pre/post-surgical outcomes are improved by identifying and treating patients with dry eye.


Reduce post-surgical complications, such as corneal wound healing, by identifying dry eye prior to surgery.


Therapeutic treatment of dry eye improves patient quality of life.


3 products

Showing 1 - 3 of 3 products

Showing 1 - 3 of 3 products